In Prosthetics and Robotics, Bigger Is Becoming Better

Deal-making is accelerating in prosthetics and robotics as companies chase scale, integration, and long-term advantage

20 Jan 2026

A fresh wave of mergers and acquisitions is rapidly reshaping the US prosthetics and robotics market. The lines between technology, care delivery, and competitive survival are being redrawn, and fast.

Deal activity is accelerating on two fronts. Advanced orthopedic robotics platforms are consolidating at the top, while prosthetics and orthotics clinics are racing to build national footprints. For industry leaders, the signal is clear. Scale paired with technology is no longer optional.

One defining transaction closed on October 7, 2025, when Zimmer Biomet completed its acquisition of Monogram Technologies. The deal deepens Zimmer Biomet’s robotics capabilities, strengthening its push toward robot-assisted surgery and future automation. Hospitals are increasingly looking for integrated surgical ecosystems rather than a patchwork of tools. Acquisitions like this help large manufacturers lock in health system relationships and defend market share.

Consolidation is also accelerating on the patient care side. In late 2025 and early 2026, prosthetics and orthotics clinics saw a surge of completed deals. Eqwal has been among the most active buyers, expanding its national reach through a series of acquisitions. Recent additions include United Prosthetics in Massachusetts, American Orthopedics in Ohio, and Prosthetic & Orthotic Group, which adds nine locations across California and Colorado.

The Prosthetic & Orthotic Group deal stands out for its California expansion. The state’s large patient population and dense healthcare infrastructure make it a strategic prize. Eqwal president Jean-Pierre Mahé has pointed to California as central to both growth ambitions and patient impact.

For patients, larger clinic networks can mean better access, broader services, and more consistent care across locations. For operators, scale brings advantages in recruiting, training, and navigating increasingly complex reimbursement systems.

But growth through acquisition carries risk. Integrating teams, maintaining care standards, and preserving patient trust remain hard tests, especially in long-term and pediatric care.

Even so, the momentum is unmistakable. As robotics becomes more central to orthopedic care and clinic networks extend their reach, the sector is entering a more competitive, opportunity-rich phase. Those that scale with discipline may define the market’s next chapter.